Filing Details
- Accession Number:
- 0001562180-17-001430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-04 16:01:26
- Reporting Period:
- 2017-04-03
- Filing Date:
- 2017-04-04
- Accepted Time:
- 2017-04-04 16:01:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591098 | Duane Nash | C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-04-03 | 991 | $9.20 | 24,677 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold by reporting person pursuant to a 10b5-1 plan to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award.
- The price reported is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.19 to $9.21, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Billionaire Hedge Funds
